Progress report on the guidance for industry for statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals

Journal of Biopharmaceutical Statistics

Volumn 10, Issue 4, 2000, Pages 481-501

  Lin, K K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Death rate method; Exact test; Poly k tests; Prevalence method; Ratio trend test; Trend and pairwise comparison tests

Indexed keywords

DRUG;

ANALYTIC METHOD; ANALYTICAL ERROR; CARCINOGENICITY; CAUSE OF DEATH; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROL; DRUG INDUSTRY; EXPERIMENTATION; FOOD AND DRUG ADMINISTRATION; LETHALITY; METHODOLOGY; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANIMALS; CARCINOGENICITY TESTS; DATA INTERPRETATION, STATISTICAL; DRUG INDUSTRY; DRUG TOXICITY; GUIDELINES; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RODENTIA; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0033739507     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-100101980     Document Type: Conference Paper

References (71)

1. Carcinogenicity studies of pharmaceuticals
2. 'Chemical carcinogens; A review of the Science and its associated principles,' in Part II, Office of Science and Technology Policy
3. Bioassays of shortened duration of drugs: Statistical implications
4. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments
5. Tests for differences in tumor incidence based on animal carcinogenesis experiments
6. A comparison of tumor incidence analyses applicable in single-sacrifice animal experiments
7. Comparison of two treatments in animal carcinogenicity experiments
8. Statistical analysis of survival experiments
9. Tests for trend in life table analysis
10. An age-adjusted trend test for the tumor incidence rate
11. Testing disease dependence in survival experiments with serial sacrifice
12. Nonparametric methods for survival/sacrifice experiments
13. Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments
14. Estimating tumor incidence rates in animal carcinogenicity experiments
15. Analytic expressions for maximum likelihood estimation in a nonparametric model of tumor incidence and death
16. Animal carcinogenicity experiments with and without series Sacrifices
17. Estimation and testing of tumor incidence rates in experiments lacking cause-of-death data
18. Nonparametric trend test for the cumulative tumor incidence rates
19. Attribution of tumor lethality and estimation of time to onset of occult tumors in the absence of cause-of-death information
20. Constant risk differences in the analysis of animal tumorigenicity data
21. A three-state multiplicative model for rodent tumorigenicity experiments
22. A comparison of continuous- and discrete-time three-state models for rodent tumorigenicity experiments
23. Effects of treatment-induced mortality on tests for carcinogenicity in small samples
24. Ratio estimates, the Delta method, and quantal response tests for increased carcinogenicity
25. An age-adjusted trend tumor incidence rate for single-sacrifice experiments
26. Testing incidence of occult tumors by attributing tumor lethality in the absence of cause-of-death information
27. Regression models and life tables (with discussion)
28. Trend and homogeneity analyses of proportions and life table data
29. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship
30. A generalized Wilcoxon test for comparing K samples subject to unequal patterns of censorship
31. The analysis of exponentially distributed life-times with two types of failures
32. Logistic regression analysis of incidental-tumor data from animal carcinogenicity experiments
33. Statistical aspects of the analysis of data from retrospective studies of disease
34. Exact versus asymptotic tests of trend of tumor prevalence in tumorigenicity experiments: A comparison of P-values for small frequency of tumors
35. Statistical review and evaluation of animal tumorigenicity studies
36. Biostatistical methodology in carcinogenicity studies
37. 2 tests
38. Tests for linear trends in proportions and frequencies
39. A simple method for approximating the variance of a complicated estimate
40. Weighted P-value for animal carcinogenicity trend test
41. A reexamination of false-positive rates for carcinogenesis studies
42. A regulatory perspective on statistical methods for analyzing new drug carcinogenicity study data
43. Overall false positive rates in tests for linear trend in tumor incidence in animal carcinogenicity studies of new drugs
44. 'Guidance on testing for carcinogenicity of pharmaceuticals,' ICH-S1B
45. Control of overall false positive rates in animal carcinogenicity studies of pharmaceuticals
46. p value adjustment for multiple tests in multivariate binomial models
47. Weighted multiplicity adjustments for animal carcinogenicity tests
48. Use of historical control data in carcinogenicity studies in rodents
49. Confidence intervals for a binomial parameter after observing no success
50. Approximate binomial confidence limits
51. Confidence intervals for binomial proportion
52. Upper confidence bounds for binomial probability in safety evaluation
53. A look at the rule of three
54. The use of historical control information in testing for a trend in proportions
55. Conditional two sample tests with historical controls
56. Incorporating historical controls in testing for a trend in proportions
57. The incorporation of historical information in tests of proportions: Simulation study of Tarone's procedure
58. A stabilized moment estimator for the beta-binomial distribution
59. On the use of historical control data to estimate dose response trends in quantal bioassay
60. Combining historical and randomized controls for assessing trends in proportions
61. Use of historical controls in time-adjusted trend tests for carcinogenicity
62. On the use of historical control data for trend test in carcinogenicity studies